Showing 25 to 36 of 70 results
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Trump's Drug Pricing Order Faces Implementation Hurdles
President Trump's executive order mandates that the US pay the lowest price for drugs among peer nations, but implementation faces significant challenges due to logistical complexities, legal uncertainties, and past failures of similar initiatives.
Progress
40% Bias Score
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.
Trump Executive Order Seeks to Lower Prescription Drug Prices
President Trump issued an executive order on May 12, 2025, aiming to lower U.S. prescription drug prices by increasing prices paid by foreign countries, facing legal and practical challenges while seeking to balance consumer benefits with pharmaceutical innovation.
Progress
56% Bias Score
High US Brand-Name Drug Prices: Monopoly Pricing and Market Segregation
American consumers pay three times more for brand-name drugs than the OECD average due to drug company monopoly pricing and market segregation, despite the high development costs and risky nature of pharmaceutical innovation, which leads to unmet needs among lower-income patients.
High US Brand-Name Drug Prices: Monopoly Pricing and Market Segregation
American consumers pay three times more for brand-name drugs than the OECD average due to drug company monopoly pricing and market segregation, despite the high development costs and risky nature of pharmaceutical innovation, which leads to unmet needs among lower-income patients.
Progress
48% Bias Score
Trump's Plan to Lower US Drug Prices: Aimed at Europe
US President Donald Trump announced a plan to lower American drug prices by matching the lowest rates in other wealthy countries, potentially saving billions of dollars annually, while criticizing European drug pricing negotiations as "difficult, brutal, and nasty.
Trump's Plan to Lower US Drug Prices: Aimed at Europe
US President Donald Trump announced a plan to lower American drug prices by matching the lowest rates in other wealthy countries, potentially saving billions of dollars annually, while criticizing European drug pricing negotiations as "difficult, brutal, and nasty.
Progress
52% Bias Score
Trump's Executive Order Targets High US Drug Prices
President Trump issued a new executive order aiming to lower US drug prices by aligning them with those in Europe and the UK, impacting millions of Americans, particularly seniors on Medicare Part B; the policy's success depends on Congressional approval and potential legal challenges.
Trump's Executive Order Targets High US Drug Prices
President Trump issued a new executive order aiming to lower US drug prices by aligning them with those in Europe and the UK, impacting millions of Americans, particularly seniors on Medicare Part B; the policy's success depends on Congressional approval and potential legal challenges.
Progress
48% Bias Score
Trump's New Executive Order Targets High Medicare Drug Costs
President Trump announced a new executive order to lower Medicare Part B drug costs by matching them to the lowest prices paid by other countries, potentially saving billions of dollars but facing strong industry opposition and legal challenges.
Trump's New Executive Order Targets High Medicare Drug Costs
President Trump announced a new executive order to lower Medicare Part B drug costs by matching them to the lowest prices paid by other countries, potentially saving billions of dollars but facing strong industry opposition and legal challenges.
Progress
52% Bias Score
Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.
Trump's "Most Favored Nation" Drug Pricing Policy Risks Stifling Innovation
President Trump's executive order mandates U.S. drug prices align with lower prices in other developed countries, potentially reducing research funding, delaying new drug launches, and increasing prices elsewhere, with minimal U.S. savings.
Progress
60% Bias Score
FDA Ban on Compounded GLP-1 Drugs Restricts Access for Thousands
The FDA's ban on compounded GLP-1 medications, effective this week, will restrict access for thousands of patients who rely on these lower-cost alternatives for weight loss and diabetes, despite concerns about potential shortages and insurance coverage challenges.
FDA Ban on Compounded GLP-1 Drugs Restricts Access for Thousands
The FDA's ban on compounded GLP-1 medications, effective this week, will restrict access for thousands of patients who rely on these lower-cost alternatives for weight loss and diabetes, despite concerns about potential shortages and insurance coverage challenges.
Progress
60% Bias Score
Trump Threatens Tariffs to Slash US Drug Prices
President Trump signed a decree on July 2024, threatening trade barriers against foreign pharmaceutical companies unless they lower US drug prices by up to 90% within 30 days; this follows a study showing US drug prices are up to 40% higher than in Europe, with examples like Eliquis costing $606 in ...
Trump Threatens Tariffs to Slash US Drug Prices
President Trump signed a decree on July 2024, threatening trade barriers against foreign pharmaceutical companies unless they lower US drug prices by up to 90% within 30 days; this follows a study showing US drug prices are up to 40% higher than in Europe, with examples like Eliquis costing $606 in ...
Progress
52% Bias Score
Trump's Trade Deal Averts Economic Crisis; Supreme Court Divided on Birthright Citizenship
President Trump reached a trade deal with China, averting economic crisis, using a strategy of tariff threats that led to de-escalation and subsequent bilateral talks to reduce the US trade deficit. The US Supreme Court shows increasing division on birthright citizenship, a judge refused to block IR...
Trump's Trade Deal Averts Economic Crisis; Supreme Court Divided on Birthright Citizenship
President Trump reached a trade deal with China, averting economic crisis, using a strategy of tariff threats that led to de-escalation and subsequent bilateral talks to reduce the US trade deficit. The US Supreme Court shows increasing division on birthright citizenship, a judge refused to block IR...
Progress
20% Bias Score
Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Trump Signs Executive Order to Slash Prescription Drug Prices
President Trump signed an executive order on Monday implementing a 'most favored nation' policy to lower U.S. prescription drug prices to match the lowest prices paid internationally, targeting high-cost drugs like Ozempic and aiming for a 59% price reduction.
Progress
64% Bias Score
Trump Orders Massive US Drug Price Cuts
President Trump signed an executive order mandating a 30-80% reduction in US federal government drug prices within 30 days, leveraging a "most favored nation" policy to match the lowest prices in other developed countries, impacting Medicare and Medicaid.
Trump Orders Massive US Drug Price Cuts
President Trump signed an executive order mandating a 30-80% reduction in US federal government drug prices within 30 days, leveraging a "most favored nation" policy to match the lowest prices in other developed countries, impacting Medicare and Medicaid.
Progress
52% Bias Score
Showing 25 to 36 of 70 results